It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Jonathan Mark Hopper net worth and biography

Jonathan Hopper Biography and Net Worth

Insider of Vericel

Jon Hopper is a seasoned industry executive with previous experience as a surgeon and government regulator. He qualified in medicine in the UK in 1987 and trained as an Orthopaedic and Trauma surgeon, gaining additional clinical experience in Accident and Emergency, Sports Medicine and Trauma Intensive Care. Jon became a Fellow of the Royal College of Surgeons of Edinburgh in 1992. In 1997, he joined the UK’s Senior Civil Service as a senior medical officer at the UK’s Department of Health, regulating medical device manufacturers and advising senior government officials and Ministers of State. Jon attained the degree MBA (Health Executive) from the University of Keele 2003. In 2006, Jon joined the medical device industry and moved to the USA in 2009. He has held various Global Medical Affairs and Clinical Development Executive roles for ConvaTec, Stryker, Osiris Therapeutics and Ferring Pharmaceuticals. Jon joined Vericel in August 2018 and leads the Clinical Development, Pharmacovigilance and Medical Affairs functions.

What is Jonathan Mark Hopper's net worth?: The estimated net worth of Jonathan Mark Hopper is at least $1.60 million as of March 30th, 2021. Dr. Hopper owns 27,966 shares of Vericel stock worth more than $1,601,333 as of November 21st. This net worth evaluation does not reflect any other investments that Dr. Hopper may own. Additionally, Dr. Hopper receives an annual salary of $672,160.00 as Insider at Vericel. Learn More about Jonathan Mark Hopper's net worth.
How old is Jonathan Mark Hopper?: Dr. Hopper is currently 62 years old. There are 3 older executives and no younger executives at Vericel. Learn More on Jonathan Mark Hopper's age.
What is Jonathan Mark Hopper's salary?: As the Insider of Vericel Co., Dr. Hopper earns $672,160.00 per year. There are 3 executives that earn more than Dr. Hopper. The highest earning executive at Vericel is Mr. Dominick C. Colangelo Esq., CEO, President & Director, who commands a salary of $1,540,000.00 per year. Learn More on Jonathan Mark Hopper's salary.
How do I contact Jonathan Mark Hopper?: The corporate mailing address for Dr. Hopper and other Vericel executives is 64 SIDNEY STREET, CAMBRIDGE MA, 02139. Vericel can also be reached via phone at (617) 588-5555 and via email at [email protected]. Learn More on Jonathan Mark Hopper's contact information.
Has Jonathan Mark Hopper been buying or selling shares of Vericel?: Jonathan Mark Hopper has not been actively trading shares of Vericel in the last ninety days. Most recently, Jonathan Mark Hopper sold 14,881 shares of the business's stock in a transaction on Wednesday, December 22nd. The shares were sold at an average price of $40.11, for a transaction totalling $596,876.91. Learn More on Jonathan Mark Hopper's trading history.
Who are Vericel's active insiders?: Vericel's insider roster includes Sean Flynn (VP), Steven Gilman (Director), Michael Halpin (COO), Jonathan Hopper (Insider), and Paul Wotton (Director). Learn More on Vericel's active insiders.
Are insiders buying or selling shares of Vericel?: During the last year, insiders at the biotechnology company sold shares 20 times. They sold a total of 176,650 shares worth more than $7,927,426.06. The most recent insider tranaction occured on October, 16th when CEO Dominick Colangelo sold 17,500 shares worth more than $724,150.00. Insiders at Vericel own 5.2% of the company. Learn More about insider trades at Vericel.
Information on this page was last updated on 10/16/2024.

Jonathan Mark Hopper Insider Trading History at Vericel

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/22/2021	Sell	14,881	$40.11	$596,876.91
12/20/2021	Sell	1,000	$40.00	$40,000.00
3/30/2021	Sell	17,924	$51.40	$921,293.60	27,966

Jonathan Mark Hopper Buying and Selling Activity at Vericel

Vericel Company Overview

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $57.79

$57.31

$58.18

50 Day Range

MA: $45.61

$40.05

$57.26

2 Week Range

Now: $57.79

$32.31

$58.18

Volume

21,994 shs

Average Volume

428,557 shs

Market Capitalization

$2.85 billion

P/E Ratio

963.33

Dividend Yield

N/A

Beta

1.66

Tesla Execs are Freaking Out

From Angel Publishing | Ad

Click here to get the details.

Jonathan Hopper Biography and Net Worth

What is Jonathan Mark Hopper's net worth?

How old is Jonathan Mark Hopper?

What is Jonathan Mark Hopper's salary?

How do I contact Jonathan Mark Hopper?

Has Jonathan Mark Hopper been buying or selling shares of Vericel?

Who are Vericel's active insiders?

Are insiders buying or selling shares of Vericel?